Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06409364 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage

Study acronym: FLASH
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Nov 1, 2024 to Aug 13, 2025 · Study sites: 0 to 16v4 Show 2 more changesShow less
    • Start date changed from estimate of Nov 1, 2024 to Aug 13, 2025
    • Study sites: 0 to 16
  3. Start date: Jul 1, 2024 to Nov 1, 2024 Interventions: Fludrocortisone (Drug) to Fludrocortisone (Drug), Placebo (Drug) · Eligibility criteria shortened, about 13 words · Secondary endpoints: details revised at 1 of 1 entryv3 Show 3 more changesShow less
    • Interventions: Fludrocortisone (Drug) to Fludrocortisone (Drug), Placebo (Drug)
    • Eligibility criteria shortened, about 13 words
    • Secondary endpoints: details revised at 1 of 1 entry

    See this version in full on ClinicalTrials.gov ↗

  4. Secondary endpoints: details revised at 1 of 1 entryv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A multi-centre, prospective, blinded, randomised clinical trial of fludrocortisone compared with placebo in patients presenting with aneurysmal subarachnoid haemorrhage. The study aim is to determine if early administration of enteral fludrocortisone in aneurysmal subarachnoid haemorrhage reduce death and dependency at six months.
Trial Details
NCT Number NCT06409364
Lead Sponsor The George Institute
Conditions Aneurysmal Subarachnoid Hemorrhage
Enrollment 524 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov